发明名称 LUNG-EXPRESSED POLYPEPTIDES
摘要 Modulators of phosphatidic acid phosphatase type 2C and other polypeptides, highly expressed in cancers as compared to normal tissues, are provided for treatment of proliferative disorders such as cancer. A method is provided for detecting polypeptides that are overexpressed in cancer, whereby antibodies or binding proteins that specifically recognize these molecules are contacted with a patient's bodily fluid. The method provides an early diagnosis of cancer, and can detect recurrence and metastasis following an initial diagnosis. The invention further provides methods of treating cancer with therapeutic agents directed toward these protein and peptide biomarkers.
申请公布号 WO2005011619(A2) 申请公布日期 2005.02.10
申请号 WO2004US02655 申请日期 2004.01.30
申请人 FIVE PRIME THERAPEUTICS, INC.;HESTIR, KEVIN;LEE, ERNESTINE;CHU, KETING;WANG, YAN;PIERCE, KRISTEN;COLLINS, AMY L., TSUI;WILLIAMS, LEWIS, THOMAS 发明人 HESTIR, KEVIN;LEE, ERNESTINE;CHU, KETING;WANG, YAN;PIERCE, KRISTEN;COLLINS, AMY L., TSUI;WILLIAMS, LEWIS, THOMAS
分类号 A61K;A61K6/00;C07K16/40;G01N33/574 主分类号 A61K
代理机构 代理人
主权项
地址